Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes
✍ Scribed by Linda L. Xu; Yong Ping Su; Ron Labiche; Takehiko Segawa; Naga Shanmugam; David G. McLeod; Judd W. Moul; Shiv Srivastava
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- French
- Weight
- 247 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0020-7136
- DOI
- 10.1002/ijc.1196
No coin nor oath required. For personal study only.
✦ Synopsis
Quantitative expression profile of androgen-regulated genes (ARGs) was evaluated in the hormone-responsive prostate cancer cell line LNCaP by serial analysis of gene expression (SAGE). A total of 83,489 SAGE tags representing 23,448 known genes or expressed sequence tags (ESTs) and 1,655 potentially novel sequences have unraveled the transcriptome of LNCaP cells, the most common cell line used in prostate cancer research. Comparison of transcripts between control and R1881-treated LNCaP cells revealed the induction of 136 genes and repression of 215 genes in response to androgen (p < 0.05). Strikingly, a high fraction ( approximately 90%) of ARGs identified in our study has not been described as ARGs previously. A number of prostate-specific transcription factors were among the ARGs identified here. Classification of the ARGs on the basis of biochemical functions revealed that a great majority of ARGs identified in our experimental system appear to be involved in regulation of transcription, splicing, ribosomal biogenesis, mitogenesis, bioenergetics and redox processes. One of the novel aspects of androgen signaling included androgen regulation of genes involved in DNA repair/recombination process. By comparing our LNCaP-C and LNCaP-T SAGE libraries with SAGE tag libraries available at the NCBI-SAGE website, we have identified >200 potential prostate specific/abundant transcripts. The discovery of new prostate-specific genes and ARGs provides a unique opportunity to determine the role of these genes in prostate cell growth, differentiation and tumorigenesis.
📜 SIMILAR VOLUMES
## Abstract The vast majority of androgen‐dependent prostate tumors progress toward incurable, androgen‐independent tumors. The identification of androgen‐responsive genes, which are still actively transcribed in the tumors of patients who have undergone androgen ablation, may shed light on the mol
u-PA contributes to CaP progression, especially in the metastatic androgen-insensitive state. In vitro, u-PA is expressed by androgen-insensitive, but not androgen-sensitive, CaP cell lines. We hypothesized that in androgen-sensitive CaP an activated ARE represses u-PA expression but in androgen-ins
## Abstract In hope of eventually identifying defects in human prostatic neoplasias that render them insensitive to anti‐androgen therapy, we have examined the regulation of components of ligand‐induced cell death pathways during castration‐induced regression of the prostate. Rat prostates were obt
BACKGROUND. Homeobox genes encode transcription factors involved in the genetic control of normal development and differentiation, as well as in malignant transformation. To begin to assess the possible role of homeobox genes in prostatic cell carcinogenesis, we surveyed initially for expression of
## Abstract __NDRG3__ belongs to the N‐myc down‐regulated gene (NDRG) family that contains 4 paralogs: __NDRG1,__ ‐__2__, ‐__3__ and ‐__4__. The function of __NDRG3__ and its relationship to cancer has not been studied. We herein report our examination of the expression and biological roles of __ND